Effect of inhibition of lipolysis on heart failure following acute coronary occlusion in the dog.
D000818:Animals; D001013:Aorta, Thoracic; D001783:Blood Flow Velocity; D001794:Blood Pressure / Q000187:drug effects; D002302:Cardiac Output / Q000187:drug effects; D003331:Coronary Vessels; D003864:Depression, Chemical; D004285:Dogs; D004562:Electrocardiography; D005260:Female; D006333:Heart Failure / Q000517:prevention & control*; D006352:Heart Ventricles / Q000503:physiopathology; D007275:Injections, Intravenous; D008026:Ligation; D050356:Lipid Metabolism; D008297:Male; D000432:Methanol / Q000494:pharmacology; D009203:Myocardial Infarction / Q000150:complications* / Q000378:metabolism; D011725:Pyridines / Q000494:pharmacology; D014655:Vascular Resistance / Q000187:drug effects; D014665:Vasodilator Agents / Q000494:pharmacology
D011725:Pyridines; D014665:Vasodilator Agents; D000432:Methanol